Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-052970
Filing Date
2019-02-27
Accepted
2019-02-27 08:39:02
Documents
3
Period of Report
2019-02-27

Document Format Files

Seq Description Document Type Size
1 6-K d714747d6k.htm 6-K 9428
2 EXHIBIT 99.1 d714747dex991.htm EX-99.1 12286
3 GRAPHIC g714747g0226185006914.jpg GRAPHIC 2581
  Complete submission text file 0001193125-19-052970.txt   26473
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 19635920
SIC: 2834 Pharmaceutical Preparations